$9.07
-0.44-4.63%
At close: Dec 15, 4:00 PM EST
$8.65
-0.42-4.68%
After Hours: 4:29 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
TransCode Therapeutics Short Interest Report
RNAZNASDAQ
TransCode Therapeutics Stock Short Interest Report | NASDAQ:RNAZ | Benzinga
Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) increased during the last reporting period, rising from 35.72K to 37.99K. This put 4.14% of the company's publicly available shares short.
Based on the recent average volume of 7.72K shares traded per day, it would take 4.92 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
37.99K
Short Interest %
4.14%
Days to Cover
4.92
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics, Inc. C | 11/28/2025 | 12/09/2025 | 4.14% | 916,960 | 37,989 | 7,717 | 4.92 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/14/2025 | 11/25/2025 | 3.90% | 916,960 | 35,717 | 15,450 | 2.31 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2025 | 11/11/2025 | 2.95% | 916,960 | 27,054 | 25,598 | 1.06 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/15/2025 | 10/24/2025 | 6.40% | 916,960 | 58,698 | 742,136 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/30/2025 | 10/09/2025 | 5.22% | 833,675 | 43,523 | 13,302 | 3.27 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/15/2025 | 09/24/2025 | 7.04% | 833,675 | 58,692 | 10,503 | 5.59 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/29/2025 | 09/10/2025 | 8.27% | 833,675 | 68,937 | 11,794 | 5.85 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/15/2025 | 08/26/2025 | 10.00% | 833,675 | 83,366 | 23,314 | 3.58 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2025 | 08/11/2025 | 13.72% | 833,675 | 114,399 | 401,657 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/15/2025 | 07/24/2025 | 6.53% | 833,675 | 54,458 | 24,203 | 2.25 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/30/2025 | 07/10/2025 | 8.47% | 833,617 | 70,633 | 25,903 | 2.73 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/13/2025 | 06/25/2025 | 10.99% | 833,617 | 91,638 | 36,614 | 2.5 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/30/2025 | 06/10/2025 | 13.85% | 833,617 | 115,427 | 113,174 | 1.02 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2025 | 05/27/2025 | 13.95% | 833,617 | 116,331 | 514,289 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/30/2025 | 05/09/2025 | 4.89% | 23,341,293 | 1,141,251 | 4,926,357 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2025 | 04/25/2025 | 4.45% | 23,341,288 | 1,039,059 | 2,663,820 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/31/2025 | 04/09/2025 | — | 696,201 | 2,554,265 | 25,899,414 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/14/2025 | 03/25/2025 | 48.80% | 696,201 | 339,770 | 4,084,672 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 77.70% | 696,201 | 540,931 | 497,170 | 1.09 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 23.39% | 696,201 | 162,852 | 3,210,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 52.90% | 696,201 | 368,311 | 5,919,685 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 11.62% | 696,201 | 80,907 | 122,346 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 12.87% | 696,201 | 89,617 | 151,609 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 7.53% | 696,201 | 52,411 | 41,664 | 1.26 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 87.01% | 696,185 | 605,720 | 506,540 | 1.2 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 1.25% | 17,264,090 | 215,516 | 441,966 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 4.31% | 17,264,090 | 743,584 | 785,242 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 7.07% | 17,259,583 | 1,221,070 | 2,221,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 8.01% | 17,259,583 | 1,382,893 | 4,067,605 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 5.24% | 17,259,583 | 904,669 | 2,094,520 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 1.61% | 17,259,583 | 278,561 | 558,132 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 9.48% | 17,259,583 | 1,635,985 | 3,100,733 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 0.14% | 17,259,583 | 24,679 | 243,038 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 2.30% | 7,259,583 | 167,182 | 204,296 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 6.18% | 7,259,583 | 448,481 | 548,613 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 15.37% | 6,615,978 | 1,016,717 | 1,543,338 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 2.63% | 6,615,978 | 173,933 | 4,193,007 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 2.45% | 6,101,978 | 149,637 | 487,873 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 0.30% | 6,101,978 | 18,555 | 431,855 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 0.69% | 5,802,275 | 39,956 | 159,852 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 16.63% | 1,050,594 | 174,746 | 372,975 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 9.71% | 1,050,594 | 101,999 | 386,632 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 21.03% | 1,050,594 | 220,911 | 928,318 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 71.89% | 1,050,594 | 755,303 | 1,682,463 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 37.51% | 1,050,594 | 394,050 | 3,285,323 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 1.63% | 24,866,480 | 404,996 | 1,159,267 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 1.76% | 24,866,480 | 437,534 | 2,135,505 | 1 | Get Alert |
Looking for the most shorted stocks?
People Also Watch
TOVX
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved